Previous reports indicate that fluconazole prophylaxis can dramatically decrease the incidence of candida bloodstream infections among hematopoietic stem-cell transplant recipients, but also changes the relative proportions of candida isolates to favor organisms more resistant to fluconazole, such as Candida glabrata. Researchers from the NIH …